Prof Shankar Siva leads the Stereotactic Ablative Body Radiotherapy (SABR) program at the Peter Mac and is internationally recognised for his work in high technology radiotherapy delivery. He has designed and led 5 international investigator initiated clinical trials through TROG, and has over 300 peer reviewed publications.